(FEBRUARY 21, 2024) Brian Cunniff, Ph.D., assistant professor of pathology and laboratory medicine, spoke with WCAX-TV about a promising new treatment for mesothelioma that is being tested at the UVM Cancer Center.
Brian Cunniff, Ph.D., assistant professor of pathology and laboratory medicine
(FEBRUARY 21, 2024) Brian Cunniff, Ph.D., assistant professor of pathology and laboratory medicine, spoke with WCAX-TV about an important milestone the UVM Cancer Center has reached in its testing for a treatment for mesothelioma, an aggressive and rare form of lung cancer, and about what the advancement means for patients.
Mesothelioma has been linked to asbestos exposure and comes with a five-year survival rate of only five to 10 percent. Only two therapies have been approved for the treatment of mesothelioma since 2004, which affects about 3,000 people a year in the United States. Now, UVM researchers have started a Phase 2 trial for a promising treatment.
Read full story
at
WCAX-TV